Did you know that the federal government has a Gastrointestinal Drugs Advisory Committee? It’s true. If you don’t believe me, you can attend their upcoming meeting on February 23. The topic of the day will be a new drug application to treat hepatic encephalopathy.
Hopefully some hepatic encephalopathy sufferers will be there. They can ask the Committee why the FDA takes as long as a decade (and as much as $800 million!) to approve medications that could be helping people and saving lives right now.
Posted in Health Care, Regulation of the Day
Tagged bureaucracy, drugs, fda, fda approval, federal government, hepatic encephalopathy, hhs, prescription drugs, regulation, regulation ofthe day
If you put chlortetracycline powder in your farm animals’ drinking water to prevent disease, please be aware that a new federal rule now allows you to buy a generic version of the powder if you wish.
Actually, I probably shouldn’t be calling that rule a “rule.” As the new rule states:
This rule does not meet the definition of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because it is a rule of ‘‘particular applicability.’’
Despite the rule being called a rule twice in one sentence, it really isn’t a rule. Probably best to let logicians sort that one out.